Abstract
Organ and system remodeling is a very common process and is observed in some kidney, cardiovascular, GI, liver diseases and bronchial asthma. Main mechanism is tissue fibrosis in organs with excessive function.
Reference23 articles.
1. Фрейдлин И.С, Соколов Д.И. Кооперативные эффекты цитокинов. Конгресс РААКИ, М., 2001 (1), с. 311-324.
2. Wolf G. Angiotensin II: a pivotal factor in the progression of renal diseases. Nephrol. Dial. Transplant. 1999, v. 14 (1), p. 41-44.
3. Liu J. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kindey Int. 2006, v. 69, p. 213-217.
4. Ruiz-Ortega M., RuperezM., EstebanV, Rodriguez-vita J.. Angiotensin II: a kay factor in the inflammatory and fibrotic response in kidney diseases. Nephrol. Dial. Transplant. 2006, v. 21, p. 12-20.
5. Negri AL. Prevention of progressive fibrosis in chronic renal diseases: antifibiotic agents. J. Nephrol. 2004, v. 17, p. 496-503.